StonvexLoading…
StonvexStonvexStonvexCore line items from TSHA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.77M | $8.33M | $15.45M | $2.50M |
Operating Income | $-110.50M | $-91.46M | $-72.44M | $-162.45M |
Net Income | $-109.00M | $-89.30M | $-111.57M | $-166.01M |
EPS (Diluted) | $-0.34 | $-0.36 | $-0.96 | $-3.78 |
Total Assets | $343.32M | $160.36M | $172.73M | $126.28M |
Total Liabilities | $96.38M | $88.84M | $97.79M | $125.33M |
Cash & Equivalents | $319.77M | $139.04M | $143.94M | $87.88M |
Free Cash Flow OCF − CapEx | $-93.83M | $-81.60M | $-76.89M | $-109.01M |
Shares Outstanding | 285.05M | 204.94M | 186.96M | 63.21M |